Modulating brain's stress circuitry might prevent alzheimer's disease

In a novel animal study design that mimicked human clinical trials, researchers report that long-term treatment using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative condition.